CTEG: How can you predict if your discovery is translatable?

A presentation by David Kaplan, PhD (SickKids Research Institute) at the Bench to Bedside for Biotherapeutics (B3) Workshop held in Toronto on October 5, 2017.

In this seminar, Dr. Kaplan shares lessons learned through translating basic research findings into commercial products and clinical trials. Dr. Kaplan highlights his experience in developing two companies from work generated in his lab as well a meeting with key stakeholder to develop guidelines and set a “bar” to determine when their basic lab research was ready to move forward into a clinical trial.

This video is presented by the Clinical Translation Education Group: BioCanRx, CCRM, CellCAN, Foundation Fighting Blindness, Ontario Institute for Cancer Research, Ontario Institute for Regenerative Medicine and Stem Cell Network.

MaRS Centre, West Tower
661 University Avenue, Suite 1002
Toronto, Ontario M5G 1M1 Canada
t: 416-978-3751
f: 416-978-1368

We wish to acknowledge this land on which CCRM operates. For thousands of years, it has been the traditional land of the Huron-Wendat, the Seneca, and the Mississaugas of the Credit. Today, this meeting place is still the home to many Indigenous people from across Turtle Island and we are grateful to have the opportunity to work on this land.